Sunday, May 24

Browsing: Deruxtecan

Treatments

112 First-Line (1L) Datopotamab Deruxtecan (Dato-DXd) vs Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (mTNBC) for Whom Immunotherapy Was Not an Option: Primary Results From the Randomized, Phase 3 TROPION-Breast02 Trial

By NewsCancerMay 15, 20260

BackgroundTreatment options are limited and prognosis is poor for the approximately 70% of patients with locally recurrent inoperable or metastatic…

Support

142 Exploratory Biomarker Analysis of Trastuzumab Deruxtecan Versus Physician’s Choice of Chemotherapy in HER2-Low/Ultralow, Hormone Receptor–Positive Metastatic Breast Cancer in DESTINY-Breast06

By NewsCancerApril 30, 20260

BackgroundDESTINY-Breast06 (NCT04494425), a randomized, open-label, phase 3 trial, demonstrated a clinically meaningful progression-free survival (PFS) benefit with trastuzumab deruxtecan (T-DXd)…

Survivors

141 DESTINY-Breast06 Post Hoc Analysis by Physician’s Choice of Chemotherapy: Efficacy and Safety of Trastuzumab Deruxtecan Versus Physician’s Choice of Chemotherapy in Hormone Receptor–Positive, HER2-Low or -Ultralow Metastatic Breast Cancer

By NewsCancerApril 30, 20260

BackgroundDESTINY-Breast06 is a randomized, open-label phase 3 trial in patients with hormone receptor–positive (HR+), HER2-low (immunohistochemistry [IHC] 1+ or IHC…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Outlining Exercise as a “Biologically Interventional Therapy” for Cancer

‘Dance class helped me find a bit of myself I’d lost to cancer’

Scientists say house cats could help unlock new cancer treatments for humans

Browsing: Deruxtecan

112 First-Line (1L) Datopotamab Deruxtecan (Dato-DXd) vs Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (mTNBC) for Whom Immunotherapy Was Not an Option: Primary Results From the Randomized, Phase 3 TROPION-Breast02 Trial

142 Exploratory Biomarker Analysis of Trastuzumab Deruxtecan Versus Physician’s Choice of Chemotherapy in HER2-Low/Ultralow, Hormone Receptor–Positive Metastatic Breast Cancer in DESTINY-Breast06

141 DESTINY-Breast06 Post Hoc Analysis by Physician’s Choice of Chemotherapy: Efficacy and Safety of Trastuzumab Deruxtecan Versus Physician’s Choice of Chemotherapy in Hormone Receptor–Positive, HER2-Low or -Ultralow Metastatic Breast Cancer

Outlining Exercise as a “Biologically Interventional Therapy” for Cancer

‘Dance class helped me find a bit of myself I’d lost to cancer’

Scientists say house cats could help unlock new cancer treatments for humans

How boy who lost life to rare cancer is helping other children

Outlining Exercise as a “Biologically Interventional Therapy” for Cancer

‘Dance class helped me find a bit of myself I’d lost to cancer’

Scientists say house cats could help unlock new cancer treatments for humans

How boy who lost life to rare cancer is helping other children

Latest Post

Outlining Exercise as a “Biologically Interventional Therapy” for Cancer

‘Dance class helped me find a bit of myself I’d lost to cancer’

Scientists say house cats could help unlock new cancer treatments for humans

Subscribe to Updates

What's Hot

Browsing: Deruxtecan